
Journal of Medicinal Chemistry p. 1295 - 1299 (1984)
Update date:2022-08-05
Topics:
Strazzolini, Paolo
Malabarba, Adriano
Ferrari, Pietro
Grandi, Maria
Cavalleri, Bruno
L-Alanosine <3-(hydroxynitrosoamino)-L-alanine> is an antitumor antibiotic that at the present is undergoing phase II clinical trials.Its mode of action as well as its metabolism has been extensively studied, and the metabolite N-<(5-amino-1-β-D-ribofuran
View MoreWuhan Jadechem International Trade Co.,Ltd.
website:http://www.jadechem-intl.com
Contact:+86-27-83527060
Address:Room 502,Building C11,Software new city No.8,Huacheng Avenue,East Lake High-tech development zone,Wuhan,Hubei,China
Angelisun(Chongqing) Pharmaceutical Co., LTD.
Contact:+86-23-68030926-816
Address:D1-7 Tech & Entrepreneurs Park, Kecheng Road, Erlang Hi-Tech Areas, Chongqing, China
ZHEJIANG CHEMICAL INDUSTRY INSTITUTE TECHNOLOGY CO.,LTD(expird)
Contact:86-575-82730298
Address:shangyu
Shandong Shouguang Songchuan Industrial Additives Co.,Ltd
Contact:+86-536-8566856
Address:Shouguang,Shandong,China
ShenZhen InnoSyn Biotech Co.,Ltd
website:http://www.innosyns.com
Contact:+86-755-28351685
Address:Floor 5 & 6, Building A1, HAIKEXING Strategic Innovative Industrial Park, 16 BaoShan Road, PingShan District
Doi:10.1021/op060125+
(2006)Doi:10.1039/b607710b
(2006)Doi:10.1016/j.jorganchem.2006.05.041
(2006)Doi:10.1016/S0040-4020(01)82384-X
(1993)Doi:10.1016/0022-328X(84)80108-4
(1984)Doi:10.1021/jo00193a008
(1984)